These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10213159)

  • 1. Administration of an aldose reductase inhibitor, ONO-2235, to streptozotocin-diabetic mice restores reductions of DRG neuronal attachment to extracellular matrix proteins in vitro.
    Sango K; Horie H; Inoue S
    Neurosci Lett; 1999 Mar; 263(2-3):157-60. PubMed ID: 10213159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldose reductase inhibitor ONO-2235 restores the alterations of bladder nerve growth factor and neurotrophin receptor p75 genetic expression in streptozotocin induced diabetic rats.
    Tong YC; Cheng JT
    J Urol; 2007 Nov; 178(5):2203-7. PubMed ID: 17870109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes impairs DRG neuronal attachment to extracellular matrix proteins in vitro.
    Sango K; Horie H; Okamura A; Inoue S; Takenaka T
    Brain Res Bull; 1995; 37(5):533-7. PubMed ID: 7633902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ONO-2235, an aldose reductase inhibitor, on muscarinic receptors and contractile response of the urinary bladder in rats with streptozotocin-induced diabetes.
    Kanda M; Eto K; Tanabe N; Sugiyama A; Hashimoto K; Ueno A
    Jpn J Pharmacol; 1997 Mar; 73(3):221-8. PubMed ID: 9127817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of polyol pathway hyperactivity on protein kinase C activity, nociceptive peptide expression, and neuronal structure in dorsal root ganglia in diabetic mice.
    Uehara K; Yamagishi S; Otsuki S; Chin S; Yagihashi S
    Diabetes; 2004 Dec; 53(12):3239-47. PubMed ID: 15561956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aldose reductase inhibitor on microneurographically assessed peripheral sympathetic nerve activity in rats.
    Sato D; Kusunoki M; Shinzawa G; Feng Z; Nishina A; Nakamura T
    Auton Neurosci; 2015 Dec; 193():69-73. PubMed ID: 26272532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of aldose reductase in alterations to neurotrophin receptors and neuronal cytoskeletal protein mRNA levels in the dorsal root ganglion of streptozotocin-induced diabetic rats.
    Shimoshige Y; Enomoto R; Aoki T; Matsuoka N; Kaneko S
    Biol Pharm Bull; 2010; 33(1):67-71. PubMed ID: 20045938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an aldose reductase inhibitor on gastroenteropathy in streptozotocin-diabetic rats.
    Oya M; Hosokawa M; Tsukada H; Fukuda K; Nakamura H; Tsukiyama K; Nagashima K; Fujimoto S; Yamada Y; Seino Y
    Diabetes Res Clin Pract; 2003 Nov; 62(2):69-77. PubMed ID: 14581143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aldose reductase inhibitor on the inhibition of platelet aggregation induced by diabetic rat plasma.
    Takiguchi Y; Wada K; Nakashima M
    Eur J Pharmacol; 1992 May; 215(2-3):289-91. PubMed ID: 1396993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an aldose reductase inhibitor on altered sympathetic nerve responsiveness of isolated right atria in diabetic rats.
    Sato N; Hashimoto H; Takiguchi Y; Nakashima M
    Arzneimittelforschung; 1990 Jul; 40(7):763-6. PubMed ID: 2121149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of epalrestat, an aldose reductase inhibitor, on the generation of oxygen-derived free radicals in neutrophils from streptozotocin-induced diabetic rats.
    Kashima K; Sato N; Sato K; Shimizu H; Mori M
    Endocrinology; 1998 Aug; 139(8):3404-8. PubMed ID: 9681489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
    Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H
    Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ischaemic activity of an antioxidant aldose reductase inhibitor on diabetic and non-diabetic rat hearts.
    Calderone V; Testai L; Martelli A; La Motta C; Sartini S; Da Settimo F; Breschi MC
    J Pharm Pharmacol; 2010 Jan; 62(1):107-13. PubMed ID: 20723006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of nitric oxide production by aldose reductase inhibitor in human endothelial cells cultured in high-glucose medium.
    Okuda Y; Kawashima K; Suzuki S; Asakura Y; Asano M; Tsurumaru K; Dai H; Tachi Y; Bannai C; Saitoh M; Yamashita K
    Life Sci; 1997; 60(3):PL53-6. PubMed ID: 9000650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H; Tawata M; Aida K; Onaya T
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The absence of synergism between the effects of an aldose reductase inhibitor, epalrestat, and a vasodilator, cilostazol, on the nerve conduction slowing and the myelinated fiber atrophy in streptozotocin-induced diabetic rats.
    Sasaki H; Naka K; Kishi Y; Furuta M; Sanke T; Mukoyama M; Nanjo K
    Exp Neurol; 1997 Aug; 146(2):466-70. PubMed ID: 9270057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of sorbitol pathway and treatment effect of aldose reductase inhibitor ONO2235 in the up-regulation of cardiac M2-muscarinic receptors in streptozotocin-induced diabetic rats.
    Liu TP; Juang SW; Cheng JT; Tong YC
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):131-5. PubMed ID: 15936525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new aldose reductase inhibitor on various tissues in vitro.
    Terashima H; Hama K; Yamamoto R; Tsuboshima M; Kikkawa R; Hatanaka I; Shigeta Y
    J Pharmacol Exp Ther; 1984 Apr; 229(1):226-30. PubMed ID: 6423811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an aldose reductase inhibitor, ONO-2235, insulin and their combination on the altered responsiveness to the nerve stimulation and agonists of the isolated atria of diabetic rats.
    Hashimoto H; Satoh N; Takiguchi Y; Nakashima M
    J Pharmacol Exp Ther; 1990 May; 253(2):552-7. PubMed ID: 2159998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.
    Kojima K; Matsubara H; Harada T; Mizuno K; Suzuki M; Hotta N; Kakuta H; Sakamoto N
    Jpn J Ophthalmol; 1985; 29(1):99-109. PubMed ID: 3159927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.